Pages
Ads
Categories
- Allergies pills
- Anthelmintics
- Anti Convulsants Pills
- Anti Depressants Pills
- Antibiotics Pills
- AntiViralPill
- Arthritis pills
- Blood Pressure Pills
- Cholesterol Pills
- Diabetes Pills
- Diuretics pills
- eBook download
- Erectile Dysfunction Pills
- Gastrointestinal Pills
- Heartburn Pills
- herbal
- Hypertension pills
- Images pills
- Inflammatory
- Mens Health pills
- Muscle Relaxant Pills
- News
- Other pills
- Pain Relief Pills
- Review prices
- Skin Care Pills
- Stop Smoking Pills
- Uncategorized
- Video about ED pills
- Weight Loss Pills
- Women's Health Drugs
Blogroll
- Acomplia blog
- Advanced whois
- Buy Generic Zofran (Ondansetron)
- Buy Pills Online
- Cialis vs Levitra
- Diet Recipes Blog
- Flexyx A-Z drugs
- Generic Cialis soft tabs
- German drugstore
- Health News and Articles
- Health Signal
- Home Health Agencies
- Italian drugstore
- Natural Weight Loss
- Net Pharmacy
- Spanish drugstore
- The Canadian Rx Drugs
- Traumatology and Orthopaedics
- Viagra Mastercard
- Viagra Without Prescription
- FDA Approves Bayer HealthCare's Kogenate FS Treatment for Routine Prophylaxis in Children with Hemophilia A
- FDA Approves AstraZeneca’s Seroquel XR for the Treatment of Bipolar Depression and Bipolar Mania in the US
- FDA Approves New Injection Site for Risperdal Consta for Schizophrenia Treatment
- Watson Receives US FDA Approval for Rapaflo (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
- Akorn, Inc. Announces the FDA Approval of Akten Ophthalmic Gel 3.5%
- U.S. Food & Drug Administration Approved the use of Reyataz (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
- FDA Grants Lilly's Alimta (Pemetrexed for Injection) Third U.S. Approval
- Boston Scientific Announces FDA Approval of TAXUS Express2 Atom Stent System, First Drug-Eluting Stent For Small Vessels
- Teva's ProAir HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication
- FDA Approves Nasacort AQ Nasal Spray for Children Aged 2-5 years old
Tags
ads
USA approval for once daily Cialis pill
January 9, 2008
Eli Lilly’s once-a-day version of its erectile dysfunction (ED) treatment Cialis (tadalafil) has finally got the go ahead from US regulators, six months after approval in the EU.
The approval means the new formulation is now available to men on the other side of the Atlantic, allowing sufferers of ED 
to attempt sexual activity at any time between doses, rather than during the narrow time frame dictated by the ‘on demand’ version.
According to Lilly, the once daily Cialis formulation is intended for men who anticipate more frequent sexual activity (i.e. twice weekly), and contains a lower dose than the previously approved version that is taken as needed.
The newly approved formulation, aside from offering perhaps a more convenient and attractive option to men, will also be no more taxing on their wallets. According to Lilly, the wholesale pricing for the once-daily Cialis will be comparable to the as-needed formulation, so that patients who currently use two or more pills of the as-needed version should not have higher treatment costs through using the once-daily product.
Gaining EU approval in June last year, the once-a-day product is currently available only in parts of Europe, but introduction to further countries is expected throughout 2008.
No Comments »
No comments yet.
Fatal error: Call to undefined function: post_comments_feed_link() in /usr/home/drugrxus/domains/drugrxus.com/public_html/news/wp-content/themes/apple/comments.php on line 29